Ludwig Isell Lind af Hageby
Senior Associate, Member of the Swedish Bar AssociationProfile
I assist both Swedish and international companies with advice on mergers and acquisitions (M&A), equity capital markets and various types of corporate law matters.
In my daily work, I assist clients with advice in connection with, in particular, M&A transactions, IPOs, fundraisings, general meetings and various types of commercial agreements. I also assist Swedish and international clients with advice regarding general corporate law matters and matters relating to compliance with capital market regulations. Further, I have experience of venture capital transactions and advice regarding the creation and implementation of incentive programs in private and public companies.
2016-,
Setterwalls
2016,
Lund University, LL.M.
24 Nov 2022
Setterwalls has advised InCoax Networks in connection with rights issue and over-allotment06 Jul 2021
Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market08 Feb 2021
Setterwalls has advised SynAct Pharma in connection with SEK 80 million private placement28 Jan 2021
Setterwalls has advised Alligator Bioscience in connection with over-subscribed rights issue11 Jan 2021
Setterwalls has assisted Polygiene in connection with private placement and the acquisition of Addmaster06 Nov 2020
Setterwalls advises inRiver in connection with private placement of approximately SEK 285 million06 Oct 2020
Setterwalls has advised Guard Therapeutics in connection with rights issue and over-allotment10 Sep 2020
Setterwalls has advised InCoax Networks AB in connection with an oversubscribed rights issue10 Jul 2020
Setterwalls has advised Advenica in connection with a substantially oversubscribed rights issue27 May 2020
Setterwalls has advised BONESUPPORT in connection with SEK 378 million private placement04 Mar 2020
Setterwalls advises Qlife Holding AB in connection with the listing on Nasdaq First North Growth Market04 Dec 2019
Setterwalls advises Better Collective in connection with SEK 312 million private placement25 Jun 2019
Setterwalls has advised RhoVac in connection with a rights issue of approximately SEK 180.9 million13 Mar 2019
Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm